Daniele Bravi

1.9k total citations · 1 hit paper
38 papers, 1.5k citations indexed

About

Daniele Bravi is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Daniele Bravi has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 12 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Daniele Bravi's work include Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (16 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Daniele Bravi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (16 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Daniele Bravi collaborates with scholars based in Italy, United States and Denmark. Daniele Bravi's co-authors include M. Maral Mouradian, Angelico Carta, Menotti Calvani, Thomas N. Chase, Thomas L. Davis, Angelo Antonini, Jeffrey L. Cummings, Lynn A. Fairbanks, John W. Roberts and Fabrizio Stocchi and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Annals of Neurology.

In The Last Decade

Daniele Bravi

38 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parkinson disease therapy: current strategies and future research priorities

2024 49 citations Fabrizio Stocchi, Daniele Bravi et al. Nature Reviews Neurology profile →

Peers

Daniele Bravi

NEURO

CMN

PMH

PHYSI

D.W. Peterson United Kingdom

J. A. Temlett South Africa

Thomas Tatschner Germany

Mohab Alexander United States

EK Perry United Kingdom

Elizabeth F. Marshall United Kingdom

Fiona Bright Australia

Philippe De Witte Belgium

E.N.H. Jansen Netherlands

David G. Grahame‐Smith United Kingdom

D.W. Peterson United Kingdom

Daniele Bravi

295 ×0.5

NEURO

520 ×1.1

CMN

168 ×0.4

PMH

336 ×1.1

117 ×0.5

PHYSI

Citations per year, relative to Daniele Bravi Daniele Bravi (= 1×) peers D.W. Peterson

Countries citing papers authored by Daniele Bravi

Since Specialization

Citations

This map shows the geographic impact of Daniele Bravi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Bravi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Bravi more than expected).

Fields of papers citing papers by Daniele Bravi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Bravi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Bravi. The network helps show where Daniele Bravi may publish in the future.

Co-authorship network of co-authors of Daniele Bravi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Bravi. A scholar is included among the top collaborators of Daniele Bravi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Bravi. Daniele Bravi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stocchi, Fabrizio, Daniele Bravi, Aron Emmi, & Angelo Antonini. (2024). Parkinson disease therapy: current strategies and future research priorities. Nature Reviews Neurology. 20(12). 695–707. 49 indexed citations breakdown →

Vacca, Laura, et al.. (2021). Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson’s disease: a pilot study. Neurological Sciences. 43(2). 1055–1059. 3 indexed citations

Torti, Margherita, Daniele Bravi, Laura Vacca, & Fabrizio Stocchi. (2019). Are All Dopamine Agonists Essentially the Same?. Drugs. 79(7). 693–703. 23 indexed citations

Aleksovski, Darko, Dragana Miljković, Daniele Bravi, & Angelo Antonini. (2018). Disease progression in Parkinson subtypes: the PPMI dataset. Neurological Sciences. 39(11). 1971–1976. 73 indexed citations

Iasevoli, Felice, Carmine Tomasetti, Federica Marmo, et al.. (2010). Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. Psychopharmacology. 212(3). 329–344. 46 indexed citations

Uberti, Daniela, et al.. (2002). Pergolide protects SH-SY5Y cells against neurodegeneration induced by H2O2. European Journal of Pharmacology. 434(1-2). 17–20. 45 indexed citations

Tascedda, Fabio, Johanna Maria Catharina Blom, N. Brunello, et al.. (2001). Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. Biological Psychiatry. 50(2). 117–122. 45 indexed citations

Sacchetti, Emilio, et al.. (2000). H2 antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. Biological Psychiatry. 48(2). 167–168. 53 indexed citations

Brooks, John O., Jerome A. Yesavage, Angelico Carta, & Daniele Bravi. (1998). Acetyl L-Carnitine Slows Decline in Younger Patients With Alzheimer's Disease: A Reanalysis of a Double-Blind, Placebo-Controlled Study Using the Trilinear Approach. International Psychogeriatrics. 10(2). 193–203. 46 indexed citations

10.

Barbier, Pascaline, et al.. (1997). Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration. Journal of Neural Transmission. 104(8-9). 867–874. 19 indexed citations

11.

Metman, Leo Verhagen, Eleonora Locatelli, Daniele Bravi, M. Maral Mouradian, & Thomas N. Chase. (1997). Apomorphine responses in parkinson's disease and the pathogenesis of motor complications. Neurology. 48(2). 369–372. 79 indexed citations

12.

Metman, Leo Verhagen, Vimala H. Sethy, J. R. Roberts, et al.. (1994). Motor effects of the partial dopamine agonist (−)‐3‐(3‐hydroxyphenyl)‐N‐n‐propylpiperidine (preclamol) in Parkinson's disease. Movement Disorders. 9(5). 577–581. 10 indexed citations

13.

Bravi, Daniele, et al.. (1994). Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms. Annals of Neurology. 36(1). 27–31. 134 indexed citations

14.

Randolph, Christopher, John W. Roberts, Michael Tierney, et al.. (1994). D-Cycloserine Treatment of Alzheimer Disease. Alzheimer Disease & Associated Disorders. 8(3). 198–205. 44 indexed citations

15.

Bravi, Daniele, Thomas L. Davis, M. Maral Mouradian, & Thomas N. Chase. (1993). Treatment of parkinson's disease with the partial dopamine agonist EMD 49980. Movement Disorders. 8(2). 195–197. 15 indexed citations

16.

Carta, Angelico, et al.. (1993). Acetyl‐l‐Carnitine and Alzheimer's Disease: Pharmacological Considerations beyond the Cholinergic Sphere^a. Annals of the New York Academy of Sciences. 695(1). 324–326. 39 indexed citations

17.

Bravi, Daniele, Jeffrey J. Anderson, F. Dagani, et al.. (1992). Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Movement Disorders. 7(3). 228–231. 34 indexed citations

18.

Venturini, G, Fabrizio Stocchi, Vito Margotta, et al.. (1989). A pharmacological study of dopaminergic receptors in planaria. Neuropharmacology. 28(12). 1377–1382. 63 indexed citations

19.

Ruggieri, Stefano, Fabrizio Stocchi, Angelico Carta, et al.. (1988). Comparison between L‐Dopa and lisuride intravenous infusions: A clinical study. Movement Disorders. 3(4). 313–319. 12 indexed citations

20.

Stocchi, Fabrizio, Stefano Ruggieri, Angelo Antonini, et al.. (1988). Subcutaneous lisuride infusion in Parkinson’s disease: clinical results using different modes of administration. PubMed. 27. 27–33. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact